Lisata Therapeutics, Inc. - Common Stock (NQ:LSTA)

1.125 -0.035 (-3.02%)

Streaming Delayed Price Updated: 12:38 PM EDT, Jul 29, 2026 Add to My Watchlist

Price and Volume

Volume	240,203
Open	1.140
Bid (Size)	1.100 (100)
Ask (Size)	1.150 (500)
Prev. Close	1.160
Today's Range	1.011 - 1.230
52wk Range	1.070 - 5.070
Shares Outstanding	60,533,064
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

These stocks are moving in today's after hours session ↗

July 28, 2026

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

July 21, 2026

Via Chartmill

Performance

YTD	-42.6%	-42.6%
1 Month	-66.8%	-66.8%
3 Month	-64.8%	-64.8%
6 Month	-75.4%	-75.4%
1 Year	-57.2%	-57.2%

More News

The market is filled with gapping stocks in Tuesday's session. ↗

July 21, 2026

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

July 21, 2026

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 09, 2026

Via Benzinga

Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.

June 10, 2026

From Lisata Therapeutics, Inc.

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: KalVista Pharmaceuticals, Inc. (Nasdaq – KALV), Thermon Group Holdings, Inc. (NYSE – THR), Sila Realty Trust, Inc. (NYSE – SILA), Lisata Therapeutics, Inc. (Nasdaq –

May 14, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether NSA, LSTA, TALK are Obtaining Fair Deals for their Shareholders

May 12, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether SILA, LSTA, ESPR are Obtaining Fair Deals for their Shareholders

May 05, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Esperion Therapeutics, Inc. (Nasdaq – ESPR), Sila Realty Trust, Inc. (NYSE – SILA), Lisata Therapeutics, Inc. (Nasdaq – LSTA), SkyWater Technology, Inc. (Nasdaq -

May 05, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether SILA and LSTA are Obtaining Fair Deals for their Shareholders

May 04, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether TALK, UBFO, LSTA are Obtaining Fair Deals for their Shareholders

March 10, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.

March 06, 2026

From Lisata Therapeutics, Inc.

Via GlobeNewswire

Halper Sadeh LLC Reminds Shareholders of SKYT, NATH, SNCY, LSTA of the Firm’s Investigations

February 02, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SkyWater Technology, Inc. (Nasdaq - SKYT), Nathan’s Famous, Inc. (Nasdaq – NATH), Lisata Therapeutics, Inc. (Nasdaq – LSTA), Sun Country Airlines Holdings, Inc.

February 02, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC Encourages NATH, PEN, RAPT, LSTA Shareholders to Contact the Firm to Discuss Their Rights

January 29, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Halper Sadeh LLC Encourages SKYT, NATH, LSTA Shareholders to Contact the Firm to Discuss Their Rights

January 27, 2026

From Halper Sadeh LLC

Via GlobeNewswire

In today's session, these stocks are experiencing unusual volume. ↗

January 27, 2026

Via Chartmill

Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide

January 27, 2026

From Lisata Therapeutics, Inc.

Via GlobeNewswire

The trading volume of these stocks is deviating from the norm in today's session. ↗

January 22, 2026

Via Chartmill

LSTA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Lisata Therapeutics, Inc. is Fair to Shareholders

January 21, 2026

From Halper Sadeh LLC

Via Business Wire

Lisata Shares Nearly Double On Buyout Offer: Here Are The Details ↗

January 21, 2026

Via Stocktwits

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nathan’s Famous, Inc. (Nasdaq – NATH), Lisata Therapeutics, Inc. (Nasdaq – LSTA), Sun Country Airlines Holdings, Inc. (Nasdaq - SNCY), Ventyx Biosciences, Inc.

January 21, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer

January 21, 2026

From Lisata Therapeutics, Inc.

Via GlobeNewswire

Lisata Therapeutics (NASDAQ:LSTA) Reports Narrower-Than-Expected Q3 2025 Loss ↗

November 06, 2025

Via Chartmill

Frequently Asked Questions

Is Lisata Therapeutics, Inc. - Common Stock publicly traded?

Yes, Lisata Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Lisata Therapeutics, Inc. - Common Stock trade on?

Lisata Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Lisata Therapeutics, Inc. - Common Stock?

The ticker symbol for Lisata Therapeutics, Inc. - Common Stock is LSTA on the Nasdaq Stock Market

What is the current price of Lisata Therapeutics, Inc. - Common Stock?

The current price of Lisata Therapeutics, Inc. - Common Stock is 1.125

When was Lisata Therapeutics, Inc. - Common Stock last traded?

The last trade of Lisata Therapeutics, Inc. - Common Stock was at 07/29/26 12:38 PM ET

What is the market capitalization of Lisata Therapeutics, Inc. - Common Stock?

The market capitalization of Lisata Therapeutics, Inc. - Common Stock is 68.10M

How many shares of Lisata Therapeutics, Inc. - Common Stock are outstanding?

Lisata Therapeutics, Inc. - Common Stock has 68M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.